“The Pentagon’s focus on biological threats to troops and population centers ramped up another level this week with an $13.5 million research contract to a pharmaceutical company that uses compounds with the chemical boron to stop diseases often found in Asia and tropical climates,” USA Today reports.

“The latest award shows a continued focus on potential threats in Asia, where the Obama administration is dedicating more resources in hopes of stemming Chinese military expansion and influence.”